Author: Anna Sundin

The Lancet Infectious Diseases released this week a report on the global state of antibiotic resistance, co-authored by CDDEP Director Ramanan Laxminarayan.

The Lancet Infectious Diseases released this week a report on the global state of antibiotic resistance,
co-authored by CDDEP Director Ramanan Laxminarayan.

The JPI AMR has participated this week at the World Health Summit 2013 with a dedicated symposium on “Current Challenges in Combating Antimicrobial Resistances”.
The World Health Summit has been held in Berlin from October 20-22, 2013 with the aim to improved Health worldwide, catalyzed through collaboration and open dialogue, setting tomorrow`s agenda for improved research, education, Health care and policy outcomes.
How can we support synergies between Health and other sectors? How can we develop shared solutions to drive people-centered, inclusive development? These are only two of the questions, the World Health Summit 2013 has address and AMR has been one of the few thematic areas discussed highlighted its increasing relevance in the Health policy area.

More information at: http://www.worldhealthsummit.org/

The online form for submitting comments on the SRA draft has closed. We would like to thank all of you who read and commented the document. This is much appreciated! Your comments will now be digested by the SRA working group and necessary changes will be made to the SRA document. The finalised SRA is expected to be published in the beginning of 2014.

Winning the battle against multi-resistant bacteria.
Read more under “News and Events”
https://www.jpiamr.eu/news-and-events/video/

Canada has now become a full member of JPIAMR, increasing the member count to 19.

JPIAMR MEMBER STATES

This report, Antibiotic resistance threats in the United States, 2013 gives a first-ever snapshot of the burden and threats posed by the antibiotic-resistant germs having the most impact on human health.

Each year in the United States, at least 2 million people become infected with bacteria that are resistant to antibiotics and at least 23,000 people die each year as a direct result of these infections. Many more people die from other conditions that were complicated by an antibiotic-resistant infection.

Antibiotic resistance: The last resort

Health officials are watching in horror as bacteria become resistant to powerful carbapenem antibiotics — one of the last drugs on the shelf.

The National Natural Science Foundation of China (NSFC) and the Swedish Research Council (SRC) sponsored a workshop in Beijing on May 15-17, 2013 to promote the exchange and collaboration between the Chinese and Swedish antibiotics resistance research communities. About 20 scientists from the two countries participated in this event that addressed antibiotics and their use on humans and animals as well as the environmental impacts of antibiotics. The Institute of Materia Medica, the Institute of Medicinal Biotechnology of CAMS/PUMS hosted and organized the workshop.

Keynote speeches addressed “the task forces against bacterial infection in China” (Professor Jiandong Jiang from the Institute of Materia Medica of CAMS/PUMC) and “the global challenge of antibiotics resistance” (Professor Mate Erdelyi from the Department of Chemistry and Molecular Biology, University of Gothenburg). These talks were complemented by 16 shorter presentations by researchers from both countries.

The workshop discussions presented a large number of thoughts on antibiotics resistance policy. These included more rigorous antibiotic stewardship in Chinese hospitals and the need for evidence based interventions aiming to improve rational use of antibiotics targeting all levels of the healthcare system as well as the community and use in animals. Evaluation of interventions should take into account behavioural change theories. The socio-economic impact of antibiotic resistance was acknowledged, as well as the impact on the environment. In-depth studies on the mechanism for antimicrobial resistance are needed. Folk and traditional natural products from Traditional Chinese Medicine and medicinal herbs from Africa or India are valuable and largely untapped resources for antibiotics enhancer to reduce the occurrence of antimicrobial resistance.